472 related articles for article (PubMed ID: 32786176)
1. Assessment of mitochondrial function in metabolic dysfunction-associated fatty liver disease using obese mouse models.
Zhao QY; Ge LH; Zhang K; Chen HF; Zhan XX; Yang Y; Dang QL; Zheng Y; Zhou HB; Lyu JX; Fang HZ
Zool Res; 2020 Sep; 41(5):539-551. PubMed ID: 32786176
[TBL] [Abstract][Full Text] [Related]
2.
Yu LP; Li YJ; Wang T; Tao YX; Zhang M; Gu W; Yu J; Yang XX
World J Gastroenterol; 2023 Jan; 29(1):171-189. PubMed ID: 36683716
[TBL] [Abstract][Full Text] [Related]
3. Altered Mitochondrial Quality Control in Rats with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Induced by High-Fat Feeding.
Cioffi F; Giacco A; Petito G; de Matteis R; Senese R; Lombardi A; de Lange P; Moreno M; Goglia F; Lanni A; Silvestri E
Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205361
[TBL] [Abstract][Full Text] [Related]
4. [METTL3 inhibitor STM2457 improves metabolic dysfunction-associated fatty liver disease by regulating mitochondrial function in mice].
Gao Y; Wang P; Lu S; Ma W
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Oct; 43(10):1689-1696. PubMed ID: 37933644
[TBL] [Abstract][Full Text] [Related]
5. Effects of Pyrroloquinoline Quinone on Lipid Metabolism and Anti-Oxidative Capacity in a High-Fat-Diet Metabolic Dysfunction-Associated Fatty Liver Disease Chick Model.
Qiu K; Zhao Q; Wang J; Qi GH; Wu SG; Zhang HJ
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33535680
[TBL] [Abstract][Full Text] [Related]
6. Jiuzhuan Huangjing Pills relieve mitochondrial dysfunction and attenuate high-fat diet-induced metabolic dysfunction-associated fatty liver disease.
Mu JK; Zi L; Li YQ; Yu LP; Cui ZG; Shi TT; Zhang F; Gu W; Hao JJ; Yu J; Yang XX
Biomed Pharmacother; 2021 Oct; 142():112092. PubMed ID: 34449316
[TBL] [Abstract][Full Text] [Related]
7. Hepatic Mitochondrial Defects in a Nonalcoholic Fatty Liver Disease Mouse Model Are Associated with Increased Degradation of Oxidative Phosphorylation Subunits.
Lee K; Haddad A; Osme A; Kim C; Borzou A; Ilchenko S; Allende D; Dasarathy S; McCullough A; Sadygov RG; Kasumov T
Mol Cell Proteomics; 2018 Dec; 17(12):2371-2386. PubMed ID: 30171159
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis inhibitor liproxstatin-1 alleviates metabolic dysfunction-associated fatty liver disease in mice: potential involvement of PANoptosis.
Tong J; Lan XT; Zhang Z; Liu Y; Sun DY; Wang XJ; Ou-Yang SX; Zhuang CL; Shen FM; Wang P; Li DJ
Acta Pharmacol Sin; 2023 May; 44(5):1014-1028. PubMed ID: 36323829
[TBL] [Abstract][Full Text] [Related]
9. Thermoneutral housing does not accelerate metabolic dysfunction-associated fatty liver disease in male or female C57Bl/6J mice fed a Western diet.
Nunes JRC; Smith TKT; Ghorbani P; O'Dwyer C; Trzaskalski NA; Dergham H; Pember C; Kilgour MK; Mulvihill EE; Fullerton MD
Am J Physiol Endocrinol Metab; 2023 Jul; 325(1):E10-E20. PubMed ID: 37196059
[TBL] [Abstract][Full Text] [Related]
10. Carbon monoxide releasing molecule-A1 improves nonalcoholic steatohepatitis via Nrf2 activation mediated improvement in oxidative stress and mitochondrial function.
Upadhyay KK; Jadeja RN; Vyas HS; Pandya B; Joshi A; Vohra A; Thounaojam MC; Martin PM; Bartoli M; Devkar RV
Redox Biol; 2020 Jan; 28():101314. PubMed ID: 31514051
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Mitochondrial Function by Natural Products for the Treatment of Metabolic Associated Fatty Liver Disease.
Shi T; Yu L; Zhuang R; Xi J; He R; Shao Y; Huang J; Liu S; Yang X
Can J Gastroenterol Hepatol; 2021; 2021():5527315. PubMed ID: 34222135
[TBL] [Abstract][Full Text] [Related]
12. In vivo identification of the pharmacodynamic ingredients of Polygonum cuspidatum for remedying the mitochondria to alleviate metabolic dysfunction-associated fatty liver disease.
Yu LP; Li YQ; Li YJ; Zi L; Tao YX; Hao JJ; Zhang M; Gu W; Zhang F; Yu J; Yang XX
Biomed Pharmacother; 2022 Dec; 156():113849. PubMed ID: 36252355
[TBL] [Abstract][Full Text] [Related]
13. A Diet Induced Maladaptive Increase in Hepatic Mitochondrial DNA Precedes OXPHOS Defects and May Contribute to Non-Alcoholic Fatty Liver Disease.
Malik AN; Simões ICM; Rosa HS; Khan S; Karkucinska-Wieckowska A; Wieckowski MR
Cells; 2019 Oct; 8(10):. PubMed ID: 31597406
[TBL] [Abstract][Full Text] [Related]
14. Reduced mitochondrial mass and function add to age-related susceptibility toward diet-induced fatty liver in C57BL/6J mice.
Lohr K; Pachl F; Moghaddas Gholami A; Geillinger KE; Daniel H; Kuster B; Klingenspor M
Physiol Rep; 2016 Oct; 4(19):. PubMed ID: 27694529
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction.
Boland ML; Oldham S; Boland BB; Will S; Lapointe JM; Guionaud S; Rhodes CJ; Trevaskis JL
World J Gastroenterol; 2018 Apr; 24(16):1748-1765. PubMed ID: 29713129
[TBL] [Abstract][Full Text] [Related]
16. The severity of rat liver injury by fructose and high fat depends on the degree of respiratory dysfunction and oxidative stress induced in mitochondria.
García-Berumen CI; Ortiz-Avila O; Vargas-Vargas MA; Del Rosario-Tamayo BA; Guajardo-López C; Saavedra-Molina A; Rodríguez-Orozco AR; Cortés-Rojo C
Lipids Health Dis; 2019 Mar; 18(1):78. PubMed ID: 30927921
[TBL] [Abstract][Full Text] [Related]
17. HA-20 prevents hepatocyte steatosis in metabolic-associated fatty liver disease via regulating Ca
Wang J; Du MM; Du Y; Li JX
Eur J Pharmacol; 2022 Apr; 921():174838. PubMed ID: 35218717
[TBL] [Abstract][Full Text] [Related]
18. Elucidation of the Metabolic and Transcriptional Responses of an Oriental Herbal Medicine, Bangpungtongseong-san, to Nonalcoholic Fatty Liver Disease in Diet-Induced Obese Mice.
Choi JY; Kwon EY; Choi MS
J Med Food; 2019 Sep; 22(9):928-936. PubMed ID: 31390281
[TBL] [Abstract][Full Text] [Related]
19. GCN2 deficiency protects against high fat diet induced hepatic steatosis and insulin resistance in mice.
Liu S; Yuan J; Yue W; Bi Y; Shen X; Gao J; Xu X; Lu Z
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3257-3267. PubMed ID: 30006154
[TBL] [Abstract][Full Text] [Related]
20. Exenatide improves liver mitochondrial dysfunction and insulin resistance by reducing oxidative stress in high fat diet-induced obese mice.
Wang Z; Hou L; Huang L; Guo J; Zhou X
Biochem Biophys Res Commun; 2017 Apr; 486(1):116-123. PubMed ID: 28274877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
